Article Versions Notes

Kohli MA, Maschio M, Cartier S, Mould-Quevedo J, Fricke F-U. The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany. Vaccines. 2022; 10(9):1386. https://doi.org/10.3390/vaccines10091386

Kohli, Michele A., Michael Maschio, Shannon Cartier, Joaquin Mould-Quevedo, and Frank-Ulrich Fricke. 2022. "The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany" Vaccines 10, no. 9: 1386. https://doi.org/10.3390/vaccines10091386

Kohli, M. A., Maschio, M., Cartier, S., Mould-Quevedo, J., & Fricke, F.-U. (2022). The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany. Vaccines, 10(9), 1386. https://doi.org/10.3390/vaccines10091386